• 'The numbers don't lie': Endoscopy to become more prominent among next generation of spine surgeons
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon killed in Oklahoma hospital shooting
  • Neurosurgeon accepted $3.3M in illegal payments to perform spine surgeries at hospital
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Texas spine surgeon defending himself from 'Dr. Death 2.0' allegations
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • 4 spine technologies that promised more than they delivered
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Orthopedic surgeon's health system exit steeped in controversy
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • 22 hospitals ranked top 25 orthopedic hospitals 3+ years in a row
  • Orthopedic surgeon convicted of battery at hospital
  • UArizona neurosurgery chair dies after motorcycle collision
  • America's largest independent practices by number of spine surgeons
  • Could Medtronic's spine business be the next medtech spinoff?
  • 41 'rising stars' in orthopedics
  • Idaho orthopedic surgeon arrested for alleged misconduct at practice
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Orthopedic surgeon salaries in the 5 best, worst states for healthcare
  • New Jersey hospital must pay neurosurgeons $24.3M, appeals court rules
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Why private equity is bettering orthopedics, 3 physician leaders say
  • Florida hospital patients say they were injured during surgeries. Now a physician faces 350 lawsuits.
  • Texas spine surgeon's $11M verdict being appealed
  • A Rutgers physician accused of 'ghost surgeries' will return — but with fewer responsibilities
  • Top orthopedic hospital in every state: US News
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • Unnecessary spine cases spur class action lawsuit
  • Jury finds neurosurgeon largely responsible for paralysis, awards $15.5M in damages
  • Colorado Supreme Court rejects hospital's bid to enforce $229K spine surgery bill
  • Dr. Jon Yoon performs NHL's 4th disc replacement in 7 months
  • Who is Johnson & Johnson's next CEO? 8 things to know

    Who is Johnson & Johnson's next CEO? 8 things to know

    Alan Condon -  

    Johnson & Johnson announced Aug. 19 that Joaquin Duato will succeed Alex Gorsky as CEO of the medtech and pharmaceutical giant in January 2022.

    Eight things to know:

    1. Mr. Duato's career at Johnson & Johnson spans more than 30 years across multiple business sectors, geographies and functions.

    2. Since 2018, he has served as vice president of the executive committee, where he provides strategic direction for the pharmaceutical and consumer health sectors — a $60 billion portfolio — and oversees the global supply chain, technology and health and wellness teams.

    3. On Jan. 3, 2022, Mr. Duato will become CEO and a board member at the company, and Mr. Gorsky — who has held the role since 2012 — will transition into the executive chair role.  

    4. Last year, Mr. Duato oversaw Johnson & Johnson's response to the COVID-19 pandemic and coordinated global initiatives to protect employees' health, ensure business and supply chain continuity and accelerate the development of a COVID-19 vaccine, according to the company.

    5. He has a master of business administration degree from the Esade business school in Barcelona and a master of international management degree from Thunderbird School of Global Management in Phoenix.

    6. The boards Mr. Duato sits on include Unicef USA, Tsinghua University School of Pharmaceutical Sciences in Beijing and the Hess Corp., a global company devoted to exploring oil, gas and energy solutions.

    7. He is also the executive sponsor of Johnson & Johnson's African Ancestry Leadership Council. Mr. Duato said he is committed to nurturing a diverse, equitable and inclusive workplace — work that has been recognized by the Healthcare Businesswomen's Association when he received the Honorable Mentor award in 2017.

    8. Mr. Duato is a dual citizen of Spain and the United States.

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Webinars

    Featured Podcast

    Featured Whitepapers